The molecular genetic landscape of pancreatic cancer has been studied by whole-genome and exome sequencing, and KRAS, CDKN2A, TP53, and SMAD4 are frequently reported as mutated in pancreatic cancer [33–37]. The gene discussed is SMAD4; the disease is familial pancreatic carcinoma.